Patrick Trojer, Chief Scientific Officer at CONSTELLATION PHARMACEUTICALS INC (CNST), sold 1,250 shares at $15.00 ($19K) on 2019-11-04, disclosed to the SEC on 2019-11-06.
Scheduled sale ($19k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.00 | 100 | $2K | 8.0% |
| 2 | $15.01 | 1,150 | $17K | 92.0% |
| Total | $15.01 avg | 1,250 | $19K | 100% |
| Filing → |
| CNST | SELL | 2019-10-24 | $159K | — | Filing → |